Disney reportedly has been in talks to buy most of 21st Century Fox, including its movie studio and networks like FX and National Geographic. Sean Aune, editor-in-chief of Techno Buffalo, joined Cheddar to explain what each company would get out of the deal. Aune says Disney is interested in Fox's TV production to leverage its new streaming platform, due out next year. Disney will not gain control over Fox network or its affiliates, nor would it touch sports. And while Aune considers that running on news and sports is a risky deal, Fox can take on the challenge. In addition, a potential deal can give Disney control over Fox's Marvel properties, including rights to Star Wars, which would be huge win for the company. So if this deal does go through, what would it mean for streaming services like Netflix? Aune believes that by the time the Disney streaming service is available, Netflix will be mostly original content, a sector the company has been heavily investing in.

Share:
More In Business
McDonald's Posts Q4 Earnings Miss; McPlant Burger Takes Off
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna's Chief Medical Officer on Omicron Booster Trial, Annual Shots
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
Load More